News AZ sells rights to three older drugs to Covis for $350m AstraZeneca has agreed to sell rights to three older drugs for asthma and rhinitis to Covis Pharma for at least $350 million.
News Isomorphic Labs raises $5bn in massive third round In yet another sign of the appetite for AI companies among investors, Isomorphic Labs has raised a whopping $5bn in a Series C financing.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.